Progressive Relaxation and Psychoeducation in Patients With Hematological Malignancies
NCT ID: NCT07251348
Last Updated: 2025-11-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
75 participants
INTERVENTIONAL
2026-02-01
2026-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Music Therapy's Effect on Cancer Patients Undergoing Radiotherapy
NCT07261267
Optimizing Psychological Treatment for Pain After Breast Cancer: A Pilot Study
NCT04841928
The Effect of Relaxation Program on Coping With Stress and Anxiety Levels of Caregivers of Children With Cancer.
NCT05807295
Evaluating Stress Management Among Allogeneic HCT Caregivers
NCT05078229
Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer
NCT00498719
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
psychoeducation group; n=25: After the pre-test, 6 sessions (2 sessions per week) were planned for 3 weeks for the individuals in this group. Each session will be conducted individually with patients, face-to-face, and will last 40-45 minutes. A post-test was administered after 3 weeks. Four expert opinions were obtained regarding the content.
routine nursing care group: no intervention n=25: The 'Perceived Stress Level' scale and the 'Herth Hope Index' scale will be administered after the initial interview.
Routine nursing care was provided.After 3 weeks, the 'Perceived Stress Level' scale and the 'Herth Hope Index' scale will be administered after the
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Progressive relaxation
Progressive relaxation; n=25: After the pre-test, 6 sessions (2 sessions per week) were planned for 3 weeks for individuals in this group. Each session will be conducted individually with patients, face-to-face, and will last 40-45 minutes. The post-test was administered after 3 weeks.
PROGRESSIVE RELAXATION SESSION TITLES:
1. SESSION: Introduction, Establishing Trust and the Concept of Relaxation
2. SESSION: Coping with a Cancer Diagnosis \& Introduction to the Progressive Relaxation Technique
3. SESSION: Progressive Muscle Relaxation Application - Upper Body3
4. SESSION: Progressive Muscle Relaxation - Lower Body
5. SESSION: Whole Body Relaxation - Reinforcing the Application
6. SESSION: Integrating Progressive Relaxation into Daily Life \& Closing
Muscle Relaxation
Progressive relaxation is a relaxation technique based on tensing and relaxing muscles in sequence. The goal is to achieve physical and mental relaxation by feeling the difference between tension and relaxation. It is frequently used for stress, anxiety, sleep problems, and psychosomatic disorders. When practiced regularly, it increases a person's ability to relax and contributes to their overall well-being.
* Teaching progressive relaxation exercises to individuals diagnosed with cancer and supporting psychological well-being by reducing stress levels and increasing hope levels through these exercises (emotional gain)
* Reducing muscle tension and providing physical relaxation (psychomotor gain)
* To reduce stress and anxiety (emotional gain)
* To increase body awareness (emotional gain)
* To teach mental and physical relaxation (psychomotor gain)
* To provide emotional relief (emotional gain)
* To develop self-relaxation skills (psychomotor gain)
psychoeducation
psychoeducation; n=25: After the pre-test, 6 sessions (2 sessions per week) were planned for 3 weeks for the individuals in this group. Each session will be conducted individually with patients, face-to-face, and will last 40-45 minutes. A post-test was administered after 3 weeks. Four expert opinions were obtained regarding the content.
PSYCHOEDUCATION SESSION TITLES:
1\. SESSION: INTRODUCTION AND PROGRAM OVERVIEW 2nd SESSION: UNDERSTANDING THE DISEASE - EMPOWERING THROUGH KNOWLEDGE 3rd SESSION: IDENTIFYING PERCEIVED STRESS AND ITS EFFECTS 4. SESSION: COPING WITH STRESS AND INTRODUCTION TO HOPE 5. SESSION: UNDERSTANDING AND STRENGTHENING HOPE 6. SESSION: INTERNALIZING WHAT HAS BEEN LEARNED, MAINTAINING AND EVALUATING
psychoeducation or Atomoxetine or stimulants according to ADHD severity
Psychoeducation is a structured educational process that provides individuals with information about mental illnesses, ways to cope with stress, and healthy living skills. The goal is to help the person understand their illness and symptoms, learn coping methods, and increase their compliance with treatment. It has both an informative and a supportive aspect.
INTERVENTION B (PSYCHOEDUCATION) GROUP APPLICATION:
* A total of 6 sessions will be held with patients in intervention group B, twice a week for 3 weeks.
* Each session will last an average of 45 minutes.
* The 'Perceived Stress Level' scale and the 'Herth Hope Index' scale will be administered after the first session.
* The 'Perceived Stress Level' scale and the 'Herth Hope Index' scale will be administered after the final session.
routine nursing care
routine nursig care; n=25 No intervention was performed after the pre-test; routine nursing care was administered. The post-test was administered after 3 weeks.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Muscle Relaxation
Progressive relaxation is a relaxation technique based on tensing and relaxing muscles in sequence. The goal is to achieve physical and mental relaxation by feeling the difference between tension and relaxation. It is frequently used for stress, anxiety, sleep problems, and psychosomatic disorders. When practiced regularly, it increases a person's ability to relax and contributes to their overall well-being.
* Teaching progressive relaxation exercises to individuals diagnosed with cancer and supporting psychological well-being by reducing stress levels and increasing hope levels through these exercises (emotional gain)
* Reducing muscle tension and providing physical relaxation (psychomotor gain)
* To reduce stress and anxiety (emotional gain)
* To increase body awareness (emotional gain)
* To teach mental and physical relaxation (psychomotor gain)
* To provide emotional relief (emotional gain)
* To develop self-relaxation skills (psychomotor gain)
psychoeducation or Atomoxetine or stimulants according to ADHD severity
Psychoeducation is a structured educational process that provides individuals with information about mental illnesses, ways to cope with stress, and healthy living skills. The goal is to help the person understand their illness and symptoms, learn coping methods, and increase their compliance with treatment. It has both an informative and a supportive aspect.
INTERVENTION B (PSYCHOEDUCATION) GROUP APPLICATION:
* A total of 6 sessions will be held with patients in intervention group B, twice a week for 3 weeks.
* Each session will last an average of 45 minutes.
* The 'Perceived Stress Level' scale and the 'Herth Hope Index' scale will be administered after the first session.
* The 'Perceived Stress Level' scale and the 'Herth Hope Index' scale will be administered after the final session.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Diagnosis of hematologic malignancy
3. Ability to read and write
4. Volunteer to participate in the study
Exclusion Criteria
2. Sensory loss related to vision and hearing
3. Communication barrier
4. Physical disability
5. Respiratory distress
6. Bone marrow transplant procedure
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Necmettin Erbakan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tuba KORKMAZ ASLAN
ASSOCIATE PROFESSOR
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NEÜ-SBF-TKA-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.